関連する実験動画
Updated: Sep 10, 2025

10:36
Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
19.8K
ガラクトオリゴサカリドは,カプセルに適合する超低用量でバイフィドジェニック効果を発揮する
Lucien F Harthoorn1, Jasmine Heyse2, Aurélien Baudot2
1Clasado Biosciences Ltd., Imperium Building, Imperial Way, Worton Grange, Reading RG2 0TD, UK.
Metabolites
|August 27, 2025
まとめ
ガラクトオリゴサッカライド (GOS) は,カプセルに適合する用量で,有益な細菌と短鎖脂肪酸を増やすことで,腸内微生物群を効果的に調節します. これは健康製品のための便利な配方オプションを提供します.
科学分野:
- 微生物群の研究
- 腸の健康と栄養
- プレビオティック科学
背景:
- プリバイオティクスは 有益な微生物を 選択的に餌にすることで 健康を促進します
- 従来のプリバイオティクスの投与量は しばしば不便な投与形式を必要とします
- この研究では,腸内微生物群の調節のためのカプセル互換性ガラクトオリゴサカライド (GOS) を調査しています.
研究 の 目的:
- 大人の腸内微生物群を調節するガラクトオリゴサカライド (GOS) のカプセル対応用量の有効性を調査する.
- 微生物の組成と短鎖脂肪酸 (SCFA) 産生に対する異なるGOS用量の影響を評価する.
主な方法:
- 臨床的に検証されたバイオリアクターシステムである ex vivo SIFR® テクノロジーを利用した.
- 成人腸内微生物群に対するGOS用量 (0. 5 , 0. 75 , 1. 83 , 3. 65g) の影響を評価した (n=8).
主要な成果:
- GOSは急速に発酵し,最も低い用量でも有益なBifidobacterium種を大幅に増加させました.
- アセテート,ブチラート,プロピオネートを含むSCFAの生産を強く促進する.
- 濃縮された特定のラックノスピラセア種は,Anaerobutyricum hallii,Bariatricus comes,Blautia種,その他,最小限のガス生産.
結論:
- ガラクトオリゴサッカライド (GOS) は,カプセルに適合する投与量で,有意なプレバイオティクスの可能性を示しています.
- GOSは,栄養製品製剤と消費者の便利性のために柔軟性を高めています.
- 効果的微生物群の調節は,以前に予想されたより低いGOS用量で観察されました.
関連する概念動画
Drugs for Treatment of Constipation-Predominant IBS
331
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
331
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
303
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
303
Drugs Affecting GI Tract Motility: Other Laxatives
457
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
457
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
317
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
317
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
256
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
256
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
203
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
203

